The Science of Muscle Loss on GLP-1 Drugs — And What Supplements Can Help

The Science of Muscle Loss on GLP-1 Drugs — And What Supplements Can Help

GLP-1 receptor agonists like semaglutide and tirzepatide have revolutionised weight management. But as millions of people experience dramatic weight loss, an uncomfortable truth has emerged from clinical trials: a significant portion of that weight loss comes from muscle, not just fat.

We reviewed 25 peer-reviewed studies — including 13 systematic reviews covering thousands of participants — to understand the scope of this problem and identify the most evidence-backed supplements that may help preserve lean mass during GLP-1 therapy.

How Much Muscle Are People Actually Losing?

The numbers are striking. A network meta-analysis of 22 randomised controlled trials (N=2,258) found that approximately 25% of total weight lost on GLP-1 drugs comes from lean body mass (Karakasis et al., 2025). In the SURMOUNT-1 tirzepatide trial, patients lost 10.9% of their lean mass over 72 weeks — and this 75/25 fat-to-lean ratio was consistent regardless of age, sex, or how much weight was lost (Look et al., 2025).

For semaglutide, the picture may be even more concerning. STEP-1 participants lost an average of 6.92 kg of lean mass — roughly 40% of their total weight loss — which experts estimate equates to approximately 20 years of normal age-related muscle decline compressed into about 18 months (Mechanick et al., 2025).

There's some nuance, though. The SEMALEAN study (N=106) found that lean mass loss occurred mostly in the first 7 months and then stabilised, while handgrip strength actually improved and sarcopenia prevalence dropped from 49% to 33% (Alissou et al., 2026). This suggests that not all lean mass loss translates to functional muscle loss — some may reflect adaptive changes to a lighter body.

Still, for older adults or anyone with already-compromised muscle reserves, the risk is real and worth addressing proactively.

The Supplement Evidence, Ranked

Here's what the research actually shows about supplements that may help preserve muscle during weight loss.

Creatine: The Strongest Evidence (Grade A)

If you're resistance training while on a GLP-1 drug, creatine monohydrate has the most robust evidence base of any supplement.

The largest meta-analysis ever conducted on creatine and body composition — 143 studies with 3,655 participants — found that creatine supplementation increased fat-free mass by +0.82 kg, rated as GRADE high-quality evidence (Pashayee-Khamene et al., 2024). There's a confirmed dose-response relationship: more creatine means more lean mass preservation.

For adults over 50 specifically, the numbers are even better: +1.32 kg of lean tissue mass (p<0.000001) across 16 RCTs (Forbes et al., 2021). Interestingly, lower doses (≤5 g/day) without a loading phase actually produced the largest gains (+1.81 kg), making the protocol both effective and simple.

The catch: Every creatine study involved concurrent resistance training. We don't have data on creatine during caloric restriction without exercise. If you're not doing some form of resistance training, the evidence doesn't directly apply.

Practical dose: 3–5 g/day of creatine monohydrate. No loading phase needed. Pair with resistance training at least twice per week.

Protein: The Non-Negotiable Foundation (Grade B)

Multiple expert panels recommend protein intake of 1.0–1.5 g/kg adjusted body weight per day as the foundational strategy for muscle preservation during weight loss (Mechanick et al., 2025). This is especially important for GLP-1 users whose appetite suppression often leads to dramatically reduced food intake.

The type of protein matters too. In a study of obese elderly adults on a 1,250 kcal/day diet (essentially modelling GLP-1-level caloric restriction), those consuming whey protein plus essential amino acids had a 3.8-fold higher rate of muscle protein synthesis compared to those on a casein-based replacement, plus 30% greater fat loss (Coker et al., 2012).

Practical target: At least 60 g of protein daily, emphasising whey and other leucine-rich sources. Distribute protein across meals rather than concentrating it in one sitting.

Whey + Leucine + Vitamin D: The Synergistic Trio (Grade B)

Sometimes supplements work better together. A meta-analysis of 3 RCTs in sarcopenic elderly patients (N=637, average age 77–82) found that the combination of whey protein, leucine (2.8–4 g/day), and vitamin D significantly preserved appendicular muscle mass — even without exercise (SMD 0.21, p=0.04). When exercise was added, the effect nearly doubled (SMD 0.45, p=0.01) (Chang & Choo, 2023).

This is particularly relevant for GLP-1 users who may struggle with exercise due to fatigue, nausea, or physical limitations. The multi-nutrient approach also addresses the vitamin D deficiency that develops in many GLP-1 users.

HMB: The Muscle Breakdown Blocker (Grade B)

β-Hydroxy-β-methylbutyrate (HMB) is a metabolite of leucine that works by directly inhibiting muscle protein breakdown pathways. A meta-analysis of 21 RCTs (N=1,935) in adults over 50 found that HMB at 3 g/day improved lean mass by +0.28 kg and enhanced physical function measures including chair stand time and gait speed (Li et al., 2025).

The most compelling study for the GLP-1 context: during 10 days of bed rest in older adults, HMB prevented nearly 2 kg of muscle loss compared to placebo (Deutz et al., 2013). Bed rest creates a catabolic state analogous to what happens during aggressive caloric restriction.

Important nuance: In well-nourished athletes consuming adequate protein (≥1.6 g/kg/day), HMB provided no additional benefit (Holland et al., 2022). This suggests HMB may be most valuable precisely when protein intake is suboptimal — which is common during GLP-1 therapy.

Omega-3 Fish Oil: The Anabolic Sensitiser (Grade C)

Omega-3 fatty acids don't directly build muscle, but they may make your muscles more responsive to other anabolic signals. A mechanistic study showed that 8 weeks of high-dose EPA + DHA (3.36 g/day) tripled the muscle protein synthesis response to amino acid and insulin stimulation in older adults (Smith et al., 2011).

The clinical translation is less convincing. A meta-analysis of 10 RCTs found modest muscle mass gains (+0.33 kg) with omega-3 supplementation, but the effect was fragile — it disappeared when a single cancer-patient study was removed from the analysis (Huang et al., 2020).

Practical dose: >2 g/day of combined EPA + DHA. Best viewed as an adjunct that enhances the effectiveness of protein and amino acid intake rather than a standalone muscle preserver.

Vitamin D: Necessary but Not Sufficient

Here's what the largest meta-analysis (35 RCTs, N=6,628) conclusively shows: vitamin D supplementation alone does not preserve muscle mass (Widajanti et al., 2024). The effect size was essentially zero (SMD 0.05, p=0.79).

However, over 22% of GLP-1 users develop nutritional deficiencies by 12 months, with vitamin D intake at only 20% of recommended levels (Urbina et al., 2026). So supplementing vitamin D is important for overall health — just don't expect it to protect your muscles on its own. It works best as part of the whey + leucine + vitamin D combination described above.

The Elephant in the Room

We need to be transparent about one critical limitation: no supplement has been tested in a randomised controlled trial specifically during GLP-1 therapy. Every recommendation above is extrapolated from research in weight-loss, ageing, and sarcopenia populations.

The metabolic environment created by GLP-1 drugs — altered appetite signalling, improved insulin sensitivity, reduced intramuscular fat — may differ from voluntary dieting or age-related muscle loss. Supplements that work in one context may behave differently in another.

That said, the biological mechanisms are sound. Muscle protein synthesis, mTOR signalling, and protein balance don't fundamentally change because of how the caloric deficit was created. The extrapolation is reasonable even if it hasn't been directly confirmed.

A Practical Protocol

Based on the evidence, here's a tiered approach:

For everyone on a GLP-1 drug:

  • Protein: ≥1.0 g/kg/day (minimum 60 g/day)
  • Resistance training: 2–3 sessions per week
  • Multivitamin with vitamin D (≥4,000 IU), calcium, iron, magnesium

If you're actively resistance training:

  • Add creatine monohydrate: 3–5 g/day (strongest evidence)

If you can't exercise or have low protein intake:

  • Add HMB: 3 g/day
  • Consider whey + leucine + vitamin D combination products

For maximum protection (especially if over 50 or high-risk):

  • All of the above, plus omega-3 fish oil >2 g/day
  • Consider DXA body composition monitoring with your doctor

The Bottom Line

GLP-1 drugs don't discriminate perfectly between fat and muscle. But a strategic combination of resistance training, adequate protein, and targeted supplementation can shift the balance toward preserving the muscle you need while losing the fat you don't.

The evidence isn't perfect — we desperately need clinical trials of these supplements specifically in GLP-1 populations. But the mechanisms are sound, the safety profiles are well-established, and the potential downside of losing 20 years' worth of muscle in 18 months makes a proactive approach worth considering.

Download the Research

This article is based on a review of 25 peer-reviewed studies published between 2011 and 2026. It is intended for educational purposes and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.

CCLabs Research — research@cclabs.uk — https://cclabs.shop

Back to blog